Resources

4 Resources for

research & development and scientist

Subscribe to this listing via:
RSS
Email

Did you mean R&D (1,718 results)

BNET Resources

The Value Of Openness In Scientific Problem Solving: Openness and free information sharing amongst scientists are supposed to be core norms of the scientific community. However, many studies have shown that these norms are not universally followed. Lack of openness and transparency means that scientific problem solving is constrained to a few scientists who work in secret and...; Tags: Research & Development, Business Operations, Scientist, Problem, R&D, Harvard College; White papers 2006-10-01
Academic Freedom, Private-Sector Focus, and the Process of Innovation: This paper develops a model that clarifies the respective advantages and disadvantages of academic and private-sector research. The model assumes full protection of intellectual property rights at all stages of the development process, and hence does not rely on lack of appropriability or spillovers to generate a rationale for academic...; Tags: Research, Innovation, National Bureau Of Economic Research, Scientist, Intellectual Property, Leadership, Strategy, Research & Development, Business Operations, Management; White papers 2005-08-01
Bioterrorism Countermeasure Development: Issues in Patents and Homeland Security: This report explores the role of patents in encouraging the development and commercialization of new inventions and discusses the relationships between patent ownership and the generation of biomedical products. However, the grant of a patent on a pharmaceutical does not permit marketing of the product without the approval of the...; Tags: FDA, Patent, R&D, Bioterrorism, Scientist, Biomedical, Homeland Security, Research & Development, Federal Government, Healthcare, Business Operations, Government; White papers 2005-05-06
GSK Roiled by Layoffs: 350 R&D Staff Cut; Scientists in Italy Stage a Strike: Confusion continues at GlaxoSmithKline this morning as R&D employees attempt to figure out if they'll be receiving pink slips and their bosses attempt to keep everyone calm. Tension at the company has been building since Chemistry World reported that GSK sought hundreds of job cuts internationally at...; Tags: Job, Layoff, R&D, Strike, Discovery, Scientist, Italy, GSK, Restructure, Research & Development, Recruitment & Selection, Business Operations, Human Resources, Workforce Management, Jim Edwards; Blog posts 2008-08-05

Additional Resources

Monsanto Commits to Double Yield in Three Major Crops: FOOD AND BEVERAGE CLOSE-UP-8 June 2009-Monsanto Commits to Double Yield in Three Major CropsC2008 - CloseUpMedia - newsdesk@closeupmedia.com Monsanto Company announced a three-point commitment to help increase food production in the face of growing demand, limited natural resources and a changing climate. It...; Articles 2009-06-08

John Orr Crites : in memoriam: John Orr Crites, one of the leading vocational psychologists of the 20th century, succumbed to pneumonia on March 15, 2007. With his passing, counsel ling psychology lost an exemplar of its scientist-practitioner model. Jack's scholarly contributions and leadership substantially advanced vocational psychology both as a distinct discipline...; Articles 2008-09-22
Fujitsu Donates Supercomputer to the Computer History Museum: Fujitsu has donated to the Computer HistoryMuseum several components based on technologies developed for the NumericalWind Tunnel supercomputer, which was ranked No. 1 when it debuted in theTop 500 Supercomputer Sites list in November 1993. The museum will acceptthe gift at a dedication ceremony on Sept. 12, 2008, at the...; Articles 2008-08-27
MutualArt.com Passes Member Milestone and Opens New R&D Center: NEW YORK, Aug. 26 /PRNewswire/ -- MutualArt.com (http://mutualart.com/), the website that introduced content aggregation and personalization to the art public, today announced the opening of its Research and Development Center in the high tech hub of Tel Aviv, Israel, to service its rapidly growing membership. Five months after launch,...; Articles 2008-08-26
BioForce Nanosciences Announces Collaboration Agreement With UAlbany Nanocollege: BioForce Nanosciences Holdings, Inc. (OTCBB: BFNH), a leader in systems integration at the micro- and nano-scales tocreate products for the life sciences, is pleased to announce that it hasentered into a collaboration agreement with the College of NanoscaleScience and Engineering ("CNSE") of the University at Albany through whichfaculty, scientists and...; Articles 2008-08-26
Scientists ID Pathway That Makes Antipsychotic Drugs Work: New findings that antipsychotic drugs may not work as scientists have assumed could lead to changes in how the drugs are developed and prescribed, say Duke University Medical Center researchers. and along which the drugs deliver their effects -- may function differently than previously believed. the G-protein-dependent signaling pathway...; Articles 2008-08-26
Cyntellect to Collaborate With the Burnham Institute for Medical Research: In situ live cell manipulation on LEAPTM to empower purification of stem cells and their differentiated progeny SAN DIEGO, Aug. 26 /PRNewswire/ -- Cyntellect, a privately-held biotechnology company, and the Burnham Institute for Medical Research ("Burnham") today announced they have entered into a joint collaboration to develop...; Articles 2008-08-26
DTN/Meteorlogix Announces Partnership with National Center for Atmospheric Research: Partnership will help develop innovative weather products including specialized forecasts MINNEAPOLIS, Aug. 26 /PRNewswire/ -- DTN/Meteorlogix, the leading business information services company focused on agricultural, energy and weather business markets, today announced that it has formed a partnership with the National Center for Atmospheric Research NCAR. This...; Articles 2008-08-26
Proteostasis Therapeutics Secures a $45 Million Series A Financing to Develop Proteostasis Regulator Drugs: CAMBRIDGE, Mass. -- Proteostasis Therapeutics, Inc. PTI today announced that it has secured $45 million in a Series A financing to develop Proteostasis Regulator[TM] drugs as novel therapies to treat multiple genetic and degenerative disorders associated with protein homeostasis deficiencies. Investors included HealthCare Ventures, Fidelity Biosciences, New Enterprise Associates, Novartis...; Articles 2008-08-25
Prominent Scientist to Lead Intrexon's Clinical Research and Development: Dr. Sunil Chada Joins Intrexon as Senior Vice President and Will Head Company's Clinical Trials BLACKSBURG, Va. -- Intrexon, a developer of biotherapeutic control systems to enhance the safety and efficacy of existing and novel biological therapeutics, today announced the appointment of Sunil Chada, Ph.D as the Senior...; Articles 2008-08-25
Stroke sufferers take virtual road to recovery: It may look like a futuristic video game, but this virtual reality treadmill could hold the key to rebuilding lives for stroke and injury sufferers. A scientist at Portsmouth University has developed technology that can speed up recovery for patients by tricking them into believing they are...; Articles 2008-08-24
WuXi PharmaTech Promotes Dr. Rujian Ma to VP of Synthetic Chemistry: SHANGHAI, China, Aug. 22 /Xinhua-PRNewswire/ -- WuXi PharmaTech , a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced that it has promoted Dr. Rujian Ma to Vice President of Synthetic Chemistry. (Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO ) ...; Articles 2008-08-22
Laser Technology Spots Cavities Before They Start: Using lasers to spot troubled teeth before cavities form, researchers hope to turn the dentist's drill into a relic of the 20th century. The technology, called "Raman spectroscopy" RS, is not brand new. In fact, scientists in other fields have long been using it to distinguish between various chemicals, based...; Articles 2008-08-22
BOEHRINGER INGELHEIM EXTENDS RESEARCH COLLABORATION WITH ABLYNX FOR ALZHEIMER'S DISEASE: GHENT, Belgium, 21 August 2008 - Ablynx [Euronext Brussels: ABLX], apioneer in the discovery and development of Nanobodies®, a novelclass of antibody-derived therapeutic proteins, announced today thatthe Alzheimer's disease collaboration with Boehringer Ingelheim wasproceeding well and therefore the research funding has been extendedfor another year. In January 2007 Boehringer Ingelheim...; Articles 2008-08-21
Albemarle Scientists Named 'Heroes of Chemistry': BATON ROUGE, La., Aug. 21 /PRNewswire-FirstCall/ -- Twelve scientists from specialty chemical maker Albemarle Corporation and ExxonMobil Research and Engineering Company were honored by the American Chemical Society ACS in a special ceremony Sunday night as "Heroes of Chemistry" for their work in the development of NEBULAR...; Articles 2008-08-21
Scientists ID New Proteins in Programmed Cell Death: U.S. researchers have identified 170 more proteins to add to the 91 already known to be associated with programmed cell death, or apoptosis. They also uncovered new information about how these proteins may function. The findings may help in the development of new drug treatments for stroke and...; Articles 2008-08-21

<< Previous
page 1 of 1
Next >>

Content Types

Blog posts (1 results)

White papers (3 results)

Resources

research & development and scientist

BNET Resources

Additional Resources

Content Types

Premier Vendor Content Whitepapers, webcasts & resources from our Power Center Sponsors